Geez - it does look like IMU is in this game very seriously.
great to see that they have acknowledged that they need to improve communication with shareholders - a mature company approach.
5 Clinical trials underway - another 4 to start in 2023 - this is the reason for the latest CR no doubt. Getting the cash fast and in a situation where funding was scarce in the rest of the industry. Timing was good.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $80.20M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $342.6K | 922.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 138148 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 123242 | 2 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |